Novel Myasthenia Gravis Therapies Bring Opportunities
New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
Source: medscape.com
Page 25 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adverse Effects Today - Breaking & Trending Today
At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib
With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'
Source: medscape.com
Telitacicept Shows Efficacy, Safety in MTX-Resistant RA
Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.
Source: medscape.com
FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
Source: medscape.com
Metoclopramide Nasal Spray Eases Gastroparesis in Women
A nasal spray formulation of metoclopramide was well tolerated and reduced symptoms of diabetic gastroparesis in women with moderate to severe baseline symptoms in a phase 3 study
Source: medscape.com